Frequently Asked Questions
Your samples are processed in the same labs used by primary care providers, hospitals and government schemes.
Our laboratories are CLIA approved and CAP-accredited, which are the highest levels of accreditation. Tests kits are manufactured within our ISO 1385 accredited facility, the highest level of accreditation for medical devices.
Keeping your data secure is important to us. All data is completely anonymized to ensure that your privacy is maintained throughout the process. We will not share your information with any third party. All samples are disposed of following analysis.
We has a team of physicians who will review your order and results. Our nursing team is on standby throughout the testing process and, if you test positive, you will receive a call to discuss your results and treatment options.
Activation links your test kit to your account. All test kits must be activated before samples are processed.
All testing is completely anonymized to ensure that your data is protected. Your samples are processed using alphanumeric codes to ensure confidentiality. Following testing, your samples are disposed of by our CAP accredited and CLIA approved laboratories.
Your samples are processed in the same labs used by primary care providers, hospitals, and government agencies.
Our laboratories are CLIA-approved and CAP-accredited, which are the highest levels of accreditation. Tests kits are manufactured within our ISO 17025 accredited facility, the highest level of accreditation for medical devices.
Urine and blood samples are self-collected following the detailed instructions included in the kits. Samples are placed in the specimen bags provided and mailed back to the lab using the prepaid envelopes inside the kits.
Our lab uses several different assays to detect the seven tested STDs. Chlamydia, gonorrhea, and trichomoniasis are detected using a molecular testing technique known as nucleic acid amplification test (NAAT), which detects the presence of the STD DNA from a urine sample. Chemiluminescent microparticle immunoassays (CMIAs) are used to detect infections from HIV, hepatitis B, hepatitis C, and syphilis. CMIAs can detect either antigens (parts of the infectious agent) or antibodies (molecules produced by your immune system in response to an infection).
Avoiding vaginal, rectal or oral sex is the only sure-fire way to prevent STDs. If you are sexually active, male condoms when used properly, reduce the risk of getting STDs. Long-term monogamous relationships with a tested partner also reduce the risk.
All testing is completely anonymized to ensure that your data is protected. Your samples are processed using alphanumeric codes to ensure confidentiality. Following testing, your samples are disposed of by our CAP accredited and CLIA approved laboratories.
Contact a health professional to discuss any positive results as soon as possible. Additional testing is required for confirmation for several of the STDs tested. Ensure that any recent sexual partners are aware of your diagnosis so they can also request testing.
A negative result does not exclude the possibility of infection. False-negative test results may occur due to improper specimen collection, concurrent antibiotic therapy, presence of inhibitors, or organism levels below the sensitivity of the laboratory assays (which is common in the “window period” post-exposure).
False-positive (or false-reactive) results are rare. A false-positive/reactive result may also occur directly after successful antimicrobial therapy for chlamydia, gonorrhea, and trichomoniasis, immediately after hepatitis B vaccination, or in individuals previously treated for syphilis or recovered from hepatitis C. It is important to note that follow-up testing is required to confirm reactive results for HIV, syphilis, and hepatitis C.
